Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders
Environmental Science and Pollution Research, springer | Vol. 28 | Issue - | 2021
DOI: https://doi.org/10.1007/s11356-021-13320-y